Concourse Financial Group Securities’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10586 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10216 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9869 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9644 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9418 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9181 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8964 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8620 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8628 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8445 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8295 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8108 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7872 |
|